Texas 2023 - 88th Regular

Texas House Bill HB4801

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the use of the money in the Opioid Abatement Account.

Impact

The impact of HB4801 on state laws is significant as it formalizes the allocation of resources for combating the opioid epidemic. It directs state agencies to implement evidence-based strategies for prevention and treatment, which may enhance the existing framework for public health in Texas. By focusing on areas such as early intervention and the treatment of opioid addiction, this bill aims to provide a structured approach to mitigating the effects of opioid abuse on communities, particularly among vulnerable populations such as youths and those in rural areas.

Summary

House Bill 4801 focuses on managing the funds within the Opioid Abatement Account, which are designated for combatting the opioid crisis in Texas. The bill allows state agencies to utilize these funds for various initiatives aimed at preventing opioid use disorder, reducing opioid-related deaths, and supporting treatment efforts. This includes education and prevention programs targeted at school-age children, as well as increasing access to life-saving medications like naloxone.

Sentiment

Overall, the sentiment surrounding HB4801 appears to be supportive among public health advocates and professionals who view it as a necessary step toward addressing the opioid crisis. However, there may be concerns among some stakeholders about the effectiveness of the proposed measures and their implementation. The bill seems to be well-received within the legislature, with discussions likely emphasizing the dire need for improved resources and programs to aid in addiction treatment and prevention.

Contention

Notable points of contention may arise over the scope and effectiveness of the proposed measures in HB4801. Some critics might argue that while increasing access to treatment and prevention programs is crucial, the bill's provisions need to be adequately funded and supported by comprehensive strategies that address underlying issues, such as socio-economic factors contributing to opioid misuse. Ensuring that the bill effectively translates into tangible improvements in public health remains a key concern for legislators and advocates alike.

Companion Bills

No companion bills found.

Previously Filed As

TX HB537

AN ACT relating to the opioid abatement trust fund.

TX HF584

A bill for an act relating to the opioid settlement fund, establishing the opioid epidemic response advisory council, making appropriations, and including effective date provisions.

TX SB2505

Relating To Opioid Use Disorder Treatment.

TX SB337

Revises provisions relating to opioids. (BDR 40-204)

TX SB0405

Controlled substances: other; definition of governmental agency under the administration of opioid antagonist act; modify. Amends sec. 101 of 2019 PA 39 (MCL 15.671). TIE BAR WITH: SB 404'25

TX SB0404

Controlled substances: other; opioid antagonist policy; require schools to implement in certain circumstances. Amends sec. 1178 of 1976 PA 451 (MCL 380.1178) & adds sec. 1179c. TIE BAR WITH: SB 405'25

TX HB602

Providing for opioid stewardship; establishing the Opioid Reparation and Accountability Fund and the Opiate Epidemic Response Advisory Council; and imposing duties on the Department of Health, the Department of Human Services and the Department of Drug and Alcohol Programs.

TX SB2855

Relating To Opioid Antagonists.

TX HB4261

State government; Oklahoma Opioid Abatement Board; Attorney General; grantees; award contract; appeals; effective date; emergency.

TX SB0401

Health: pharmaceuticals; co-prescribing of naloxone with opioid drugs; require. Amends sec. 17744b of 1978 PA 368 (MCL 333.17744b).

Similar Bills

No similar bills found.